期刊文献+

细辛脑注射液雾化吸入辅助治疗婴幼儿下呼吸道感染疗效观察 被引量:2

Clinical Effects of Nebulized Inhalation of Asarone Injection in Treating Infants with Lower Respiratory Tract Infection
下载PDF
导出
摘要 目的:观察细辛脑注射液雾化吸入辅助治疗婴幼儿下呼吸道感染的临床疗效。方法:将110例下呼吸道感染的婴幼儿随机分为治疗组(56例)和对照组(54例)。两组均给予常规抗感染及对症治疗,治疗组加用细辛脑注射液雾化吸入治疗,对照组加用盐酸氨溴索注射液雾化吸入治疗,观察两组疗效。结果:治疗组总有效率92.86%,对照组总有效率75.93%,两组总有效率比较差异有统计学意义(P<0.05);两组症状、体征消失时间及住院时间比较,治疗组优于对照组,差异有统计意义(P<0.05)。结论:细辛脑注射液雾化吸入辅助治疗婴幼儿下呼吸道感染疗效满意,安全可靠。 Objective:To evaluate the clinical effects of nebulized inhalation of asarone injection in treatment of infants with lower respiratory tract infection.Methods:110 infants with lower respiratory tract infection were randomly divided into treatment group(56 cases)and control group(54 cases).In addition to the routine therapy,the treatment group was treated with nebulized inhalation of asarone injection,while the control group treated with nebulized ambroxol hydrochloride injection.Results:The total curative efficiency of nebulized inhalation of asarone injection in treatment group was 92.86%.It was significantly higher than that of nebulized ambroxol hydrochloride injection in control group(75.93%,P0.05).There were significant differences between the two groups on the duration of hospitalization,disappear time of pulmonary symptoms and signs(P0.05).Conclusion:Nebulized inhalation of asarone injection is rather effective,safe and reliable in treatment of infant with lower respiratory tract infections.
出处 《医学理论与实践》 2011年第19期2285-2286,共2页 The Journal of Medical Theory and Practice
关键词 细辛脑注射液 雾化吸入 婴幼儿 下呼吸道感染 Asarone injection Nebulized inhalation Infants Lower respiratory tract infection
  • 相关文献

参考文献5

二级参考文献54

共引文献221

同被引文献21

  • 1赵李宏,吴建梅,武凤兰.α-细辛脑近10年研究概述[J].中国中药杂志,2007,32(7):562-565. 被引量:56
  • 2Hu Y, Wu YY, Xia X J, et al. Development of drug-in-adhesive trans- dermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation[J]. Drug Deliv, 2011, 18(1): 84-89.
  • 3Lu H, Li J, Li M, et al. Systemic delivery of alpha-asarone with Kol- liphor HS 15 improves its safety and therapeutic effect on asthma[J]. Drug Deliv, 2015, 22(3): 266-275.
  • 4Ma WC, Zhang Q, Li H, et al. Development of intravenous lipid emulsion of α-asarone with significantly improved safety and en- hanced efficacy[J]. Int J Pharm, 2013, 450(1-2): 21-30.
  • 5Cross E, Villa-Roel C, Majumdar SR, et al. Action plans in patients presenting to emergency departments with asthma exacerbations: Fre- quency of use and description of contents [J]. Can Respir J, 2014, 21 (6): 351-356.
  • 6Isaza C, Sepu/veda-Arias JC, Agudelo BI, et al. β2-adrenoreceptor polymorphisms in asthmatic and non-asthmatic schoolchildren from colombia and their relationship to treatment response [J]. Pediatr Pul- monol, 2012, 47(9): 848-855.
  • 7Ohara Y, Ohara T, Ohrui T, et al. Exhaled carbon monoxide levels in preschool-age children with episodic asthma [J]. Pediatr Int, 2012, 54 (2): 227-232.
  • 8卢国君,王永.细辛脑注射液治疗毛细支气管炎临床研究[J].临床肺科杂志,2010,15(1):39-40. 被引量:9
  • 9梁雪.细辛脑注射液雾化吸入治疗小儿支气管哮喘临床观察[J].中国中西医结合儿科学,2010,2(2):125-126. 被引量:14
  • 10李永芳.α-细辛脑辅助治疗支气管哮喘急性发作86例疗效观察[J].牡丹江医学院学报,2010,31(5):45-47. 被引量:5

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部